Sunshine Act has very low thresholds for reporting pharma-doc ties

05/28/2013 | OncLive

The thresholds have been set quite low for reporting financial relationships between doctors and drugmakers under the Sunshine Act, Dr. Andrew L. Pecora writes. A line-item breakdown must be provided of any transfer of value exceeding $10 at a time, or $100 for a year. "Think about it: a glass of wine is not a problem; add a crab cake, however, and your name is listed on a national database. The real question is, why were the thresholds for reporting set so low?" Pecora writes.

View Full Article in:

OncLive

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC